Your browser doesn't support javascript.
loading
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Graham-Gurysh, Elizabeth; Moore, Kathryn M; Satterlee, Andrew B; Sheets, Kevin T; Lin, Feng-Chang; Bachelder, Eric M; Miller, C Ryan; Hingtgen, Shawn D; Ainslie, Kristy M.
Afiliación
  • Graham-Gurysh E; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Moore KM; Joint Department of Biomedical Engineering , University of North Carolina at Chapel Hill and North Carolina State University , Raleigh , North Carolina 27695 , United States.
  • Satterlee AB; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Sheets KT; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Lin FC; Department of Biostatistics and North Carolina Translational and Clinical Sciences Institute , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Miller CR; Division of Neuropathology, Department of Pathology and Laboratory Medicine, Departments of Neurology and Pharmacology, Lineberger Comprehensive Cancer Center, and Neuroscience Center, School of Medicine , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United Stat
  • Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
  • Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.
Mol Pharm ; 15(3): 1309-1318, 2018 03 05.
Article en En | MEDLINE | ID: mdl-29342360
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Doxorrubicina / Sistemas de Liberación de Medicamentos / Glioblastoma / Antibióticos Antineoplásicos / Recurrencia Local de Neoplasia Límite: Animals / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Doxorrubicina / Sistemas de Liberación de Medicamentos / Glioblastoma / Antibióticos Antineoplásicos / Recurrencia Local de Neoplasia Límite: Animals / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos